Related references
Note: Only part of the references are listed.Preclinical PK/PD model for combined administration of erlotinib and sunitinib in the treatment of A549 human NSCLC xenograft mice
Jing-yun Li et al.
ACTA PHARMACOLOGICA SINICA (2016)
Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?
Fabrizio Piazza et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Analyzing dendritic spine pathology in Alzheimer's disease: problems and opportunities
Mario M. Dorostkar et al.
ACTA NEUROPATHOLOGICA (2015)
Migration of blood cells to β-amyloid plaques in Alzheimer's disease
Lindsay A. Hohsfield et al.
EXPERIMENTAL GERONTOLOGY (2015)
Semi-Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for the Combination Use of Dexamethasone and Gemcitabine in Breast Cancer
Yin Yuan et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Antibody drugs for Alzheimer's show glimmers of promise
Sara Reardon
NATURE (2015)
Immune attack: the role of inflammation in Alzheimer disease
Frank L. Heppner et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
Joseph Butchart et al.
NEUROLOGY (2015)
Role of TGFβ signaling in the pathogenesis of Alzheimer's disease
Rommy von Bernhardi et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
The dynamics of monocytes and microglia in Alzheimer's disease
Peter Theriault et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
A Critique of the Drug Discovery and Phase 3 Clinical Programs Targeting the Amyloid Hypothesis for Alzheimer Disease
Eric Karran et al.
ANNALS OF NEUROLOGY (2014)
Tau-aggregation inhibitor therapy for Alzheimer's disease
Claude M. Wischik et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Identification of a functional interaction of HMGB1 with Receptor for Advanced Glycation End-products in a model of neuropathic pain
Yohance M. Allette et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
The dendritic hypothesis for Alzheimer's disease pathophysiology
J. Nicholas Cochran et al.
BRAIN RESEARCH BULLETIN (2014)
Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
P. Joshi et al.
CELL DEATH AND DIFFERENTIATION (2014)
The Glia/Neuron Ratio: How it Varies Uniformly Across Brain Structures and Species and What that Means for Brain Physiology and Evolution
Suzana Herculano-Houzel
GLIA (2014)
Alzheimer's disease: analysis of a mathematical model incorporating the role of prions
Mohamed Helal et al.
JOURNAL OF MATHEMATICAL BIOLOGY (2014)
Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events
Kiran Bhaskar et al.
NEUROBIOLOGY OF DISEASE (2014)
The LDL-HDL Profile Determines the Risk of Atherosclerosis: A Mathematical Model
Wenrui Hao et al.
PLOS ONE (2014)
Release of Neuronal HMGB1 by Ethanol through Decreased HDAC Activity Activates Brain Neuroimmune Signaling
Jian Y. Zou et al.
PLOS ONE (2014)
Mathematical model of sarcoidosis
Wenrui Hao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mathematical model of renal interstitial fibrosis
Wenrui Hao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis
George S. Bloom
JAMA NEUROLOGY (2014)
Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer's disease
Elisa Porcellini et al.
IMMUNITY & AGEING (2013)
Multi-compartmental modeling of SORLA's influence on amyloidogenic processing in Alzheimer's disease
Angelyn Lao et al.
BMC SYSTEMS BIOLOGY (2012)
Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease
Vanessa Schmidt et al.
EMBO JOURNAL (2012)
Targeting Astrocytes Ameliorates Neurologic Changes in a Mouse Model of Alzheimer's Disease
Jennifer L. Furman et al.
JOURNAL OF NEUROSCIENCE (2012)
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
Alix de Calignon et al.
NEURON (2012)
CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease
Karin Westin et al.
PLOS ONE (2012)
Proteolytic Degradation of Amyloid β-Protein
Takaomi Saido et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Alzheimer's disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory
Igor Klyubin et al.
MOLECULAR BRAIN (2012)
Current advances in the treatment of Alzheimer's disease: focused on considerations targeting A beta and tau
Yang Hong-Qi et al.
TRANSLATIONAL NEURODEGENERATION (2012)
Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where
Aaron Y. Lai et al.
FUTURE NEUROLOGY (2012)
Phagocytic Clearance in Neurodegeneration
Jennifer D. Sokolowski et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: a Step toward Model-Based Dose Optimization
Elisabet I. Nielsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
How to Get from Here to There: Macrophage Recruitment in Alzheimer's Disease
K. Rezai-Zadeh et al.
CURRENT ALZHEIMER RESEARCH (2011)
Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
Chuanyu Li et al.
Current Alzheimer Research (2011)
Tau as a Therapeutic Target for Alzheimer's Disease
A. Boutajangout et al.
CURRENT ALZHEIMER RESEARCH (2011)
The contribution of activated astrocytes to Aβ production: Implications for Alzheimer's disease pathogenesis
Jie Zhao et al.
JOURNAL OF NEUROINFLAMMATION (2011)
HMGB1 Acts on Microglia Mac1 to Mediate Chronic Neuroinflammation That Drives Progressive Neurodegeneration
Hui-Ming Gao et al.
JOURNAL OF NEUROSCIENCE (2011)
Alzheimer's disease: synapses gone cold
Robert M. Koffie et al.
MOLECULAR NEURODEGENERATION (2011)
Alzheimer's Disease: β-Amyloid Plaque Formation in Human Brain
Philip Seeman et al.
SYNAPSE (2011)
Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture
C. J. Garwood et al.
CELL DEATH & DISEASE (2011)
GSK3 and Alzheimer's disease: facts and fiction
Anna Kremer et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Interleukin 12 a Key Immunoregulatory Cytokine in Infection Applications
Therwa Hamza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2010)
Macrophages in Alzheimer's disease: the blood-borne identity
David Gate et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Structural conversion of neurotoxic amyloid-β1-42 oligomers to fibrils
Mahiuddin Ahmed et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Mathematical Modeling for the Pathogenesis of Alzheimer's Disease
Ishwar K. Puri et al.
PLOS ONE (2010)
The Concentration of Soluble Extracellular Amyloid-β Protein in Acute Brain Slices from CRND8 Mice
Jack Waters
PLOS ONE (2010)
TGF-β induces TIAF1 self-aggregation via type II receptor-independent signaling that leads to generation of amyloid β plaques in Alzheimer's disease
M-H Lee et al.
CELL DEATH & DISEASE (2010)
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease
Alex E. Roher et al.
ALZHEIMERS & DEMENTIA (2009)
The human brain in numbers: a linearly scaled-up primate brain
Suzana Herculano-Houzel
FRONTIERS IN HUMAN NEUROSCIENCE (2009)
CNS Infiltration of Peripheral Immune Cells: D-Day for Neurodegenerative Disease?
Kavon Rezai-Zadeh et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2009)
Linking Amyloid and Tau Pathology in Alzheimer's Disease: The Role of Membrane Cholesterol in Aβ-Mediated Tau Toxicity
Selina Wray et al.
JOURNAL OF NEUROSCIENCE (2009)
A quantitative comparison of rates of phagocytosis and digestion of apoptotic cells by macrophages from normal (BALB/c) and diabetes-prone (NOD) mice
Athanasius F. M. Maree et al.
JOURNAL OF APPLIED PHYSIOLOGY (2008)
A methodology for performing global uncertainty and sensitivity analysis in systems biology
Simeone Marino et al.
JOURNAL OF THEORETICAL BIOLOGY (2008)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Phosphorylation inhibits turnover of the tau protein by the proteasome:: influence of RCAN1 and oxidative stress
Diana Poppek et al.
BIOCHEMICAL JOURNAL (2006)
Role of genes and environments for explaining Alzheimer disease
M Gatz et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
High-mobility group box 1 protein (HMGB): Nuclear weapon in the immune arsenal
MT Lotze et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function
S Müller et al.
JOURNAL OF INTERNAL MEDICINE (2004)
The life span of ganglionic glia in murine sensory ganglia estimated by uptake of bromodeoxyuridine
K Elson et al.
EXPERIMENTAL NEUROLOGY (2004)
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
T Bonaldi et al.
EMBO JOURNAL (2003)
A mathematical model of the impact of novel treatments on the Aβ burden in the Alzheimer's brain, CSF and plasma
DL Craft et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2002)
Highly increased CSF tau protein and decreased β-amyloid (1-42) in sporadic CJD:: a discrimination from Alzheimer's disease?
E Kapaki et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
An anti-inflammatory drug, propagermanium, may target GPI-anchored proteins associated with an MCP-1 receptor, CCR2
S Yokochi et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)
TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice
T Wyss-Coray et al.
NATURE MEDICINE (2001)
Microglia and astrocytes in the adult rat brain: Comparative immunocytochemical analysis demonstrates the efficacy of lipocortin 1 immunoreactivity
VL Savchenko et al.
NEUROSCIENCE (2000)
Share Paper
